Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-101629
Filing Date
2024-11-22
Accepted
2024-11-22 16:30:46
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0222133-424b3_neuro.htm 424B3 255886
2 GRAPHIC image_001.jpg GRAPHIC 5234
3 GRAPHIC image_002.jpg GRAPHIC 31019
4 GRAPHIC image_003.jpg GRAPHIC 24054
  Complete submission text file 0001213900-24-101629.txt   340401
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283338 | Film No.: 241490236
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)